Ledger.Open graph →

SEC Form D · filed September 22, 2022

CND Life Sciences, Inc

Offering

$4.0M

Sold

$2.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

PHOENIX, AZ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Richard J. Morello · Atlanta, GAExec · Director Todd J. Levine · Paradise Valley, AZExec · Director Enrique J. Carrazana · Coral Gables, FLDirector Peter J. Harris · Brookline, MAExec · Director Colby Fryar · Phoenix, AZExec · Director Robert Hartog · Denver, CODirector Haakon Overli · London, United KingdomExec · Director Alex Appleton · London, United KingdomExec · Director Todd Sachse · Detroit, MIExec · Director Merredith Treaster · San Francisco, CAExec · Director Alexander M. Liang, M.D · Dallas, TXDirector Limited Liability Company Sjs GP · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗